Sub-mm Accuracy Results Measured from the First Prospective Clinical Trial of a Novel Real-Time IGRT System, Kilovoltage Intrafraction Monitoring (KIM)

P. Keall,J. A. Ng,V. Caillet,C. Y. Huang,E. Colvill,E. Simpson,P. R. Poulsen,A. Kneebone,T. Eade,J. Booth
DOI: https://doi.org/10.1016/j.ijrobp.2015.07.461
2015-01-01
Abstract:Kilovoltage intrafraction monitoring (KIM) is a novel real-time IGRT system; KIM uses the gantry-mounted kilovoltage imaging system during the therapy delivery to measure the positions of radio-opaque markers in each image, and then compute and display, in real-time, the 3D position of the center of the markers relative to the treatment isocenter. The positions are then used to determine the guidance decision: continue the treatment or gate the treatment and shift the patient. The first prospective clinical trial of KIM was performed with prostate cancer patients being treated with VMAT. We reported the accuracy and precision measurements from this trial. Kilovoltage intrafraction monitoring was used as the real-time IGRT system for the 126 fractions from the four prostate cancer patients enrolled on the study to date. For each treatment fraction the KIM real-time measurements of the prostate implanted marker positions were compared to retrospectively measured kV-MV triangulated marker positions. The kV-MV triangulated positions were considered to be the ground truth. The mean and standard deviation of the measured position differences between KIM and kV-MV triangulation in the left-right (LR), superior-inferior (SI) and anterior-posterior (AP) directions were recorded and analyzed. A variety of prostate motion magnitudes and types were observed with KIM. Gating events, exceeding 3 mm for more than 5 seconds, were required for 5-10% of the treatment fractions. The motion and gating frequency was consistent with those observed by other real-time IGRT systems. The accuracy, or mean error, of KIM in the LR, SI and AP directions was 0.1, 0.3, and -0.5 mm, respectively. The precision, or standard deviation, of KIM in the LR, SI and AP directions was 0.5, 0.3 and 0.4 mm, respectively. The fifth and 95th percentile accuracy values were within -0.8 mm and 0.7 mm in all three dimensions. A novel real-time tumor position monitoring system, KIM, has been clinically implemented and demonstrated to have sub-millimeter accuracy and precision. As KIM is implemented on a standard linear accelerator with little modification, this accurate technology can potentially be widely used on existing cancer radiation therapy systems.
What problem does this paper attempt to address?